Factors Related to Placebo Response in Randomized, Double-Blind Clinical Trials of Antidepressants in Children and Adolescents: A Meta-regression Analysis Risa OkuboKazuhiro MatsuiMamoru Narukawa Systematic Review 24 May 2023 Pages: 383 - 391
Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database Emily E. LeppienBennett J. DoughtyKenneth L. McCall Original Research Article 15 May 2023 Pages: 393 - 399
A Phase I Study to Evaluate the Pharmacokinetic Drug‒Drug Interaction of HP501, Febuxostat, and Colchicine in Male Chinese Patients with Hyperuricemia Ruilin DingLongxia ChenQing Peng Original Research Article 30 May 2023 Pages: 401 - 411
Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers Yingxin LiYang LiAixin Shi Original Research Article Open access 03 June 2023 Pages: 413 - 420
Safety, Pharmacokinetics, and Pharmacodynamics of Midazolam Gel After Rectal Administration in Healthy Chinese Subjects Sufeng ZhouJinying ZhuFeng Shao Original Research Article 04 June 2023 Pages: 421 - 433
The Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, an Oral Small Molecule Factor XIa Inhibitor, in Healthy Chinese Volunteers Junyu XuNan ZhaoYimin Cui Original Research Article 16 June 2023 Pages: 435 - 445
Safety, Tolerability, Bioavailability, and Biological Activity of Inhaled Interferon-α2b in Healthy Adults: The IN2COVID Phase I Randomized Trial Diego Garcia-HuidobroCarolina Iturriagathe IN²COVID Research Team Original Research Article 22 June 2023 Pages: 447 - 461